Explore
🏠 Home ⚙️ Dashboard 🔍 Explore 📈 Funds 🏢 AMC 🏭 Companies 📊 Sectors
Tools
🎯 Goal Planner 🔄 Fund Overlap 🧮 SIP Calculator ⏳ SWP Calculator 📊 Similar Funds
Health Care

GLAXOSMITHKLINE PHARMACEUTICALS LTD

Analyze mutual fund ownership, AMC exposure and portfolio concentration for GLAXOSMITHKLINE PHARMACEUTICALS LTD.

95
Funds Holding
88.66%
Total Exposure

📊 Quick Summary Of This Page

GLAXOSMITHKLINE PHARMACEUTICALS LTD is held by multiple mutual funds across India, making it an important institutional holding. Analyze fund ownership patterns, exposure levels and investment concentration across AMCs.
🏆
Top Mutual Fund Owners
95
Mutual funds currently holding this company.
📈
Portfolio Exposure
88.66%
Combined exposure across funds.
🏦
Participating AMCs
15
Asset management companies.
🔥 Top Funds With Highest Exposure
#1
Quant Healthcare Fund - Direct Plan QUANT
9.93%
#2
Tata India Pharma & HealthCare Fund - Direct Plan TATA
4.66%
#3
Baroda BNP Paribas Dividend Yield Fund - Direct Plan BARODABNPPARIBAS
2.77%
#4
Nippon India Pharma Fund - Direct Plan NipponIndia
2.66%
#5
Bajaj FinServ Multi Cap Fund - Direct Plan BAJAJ FINSERV
2.57%
#6
Bandhan Healthcare Fund - Direct Plan BANDHAN
2.49%
#7
Bajaj Finserv Balanced Advantage Fund - Direct Plan BAJAJ FINSERV
2.42%
#8
DSP Nifty Midcap 150 Quality 50 Index - Direct Plan DSP
2.27%
#9
The Wealth Company Flexi Cap Fund - Direct Plan THEWEALTHCOMPANY
2.16%
#10
Tata Aggressive Hybrid Fund - Direct Plan TATA
2.13%
🏆 Category Exposure
Sectoral/Thematic 31.35%
Mid Cap 6.91%
Large & Mid Cap 4.77%
Flexi Cap 4.30%
Dividend Yield 4.15%
ELSS 4.07%
Multi Cap 3.98%
Small Cap 2.68%
Dynamic Asset Allocation 2.42%
Aggressive 2.13%
🔗 Similar Companies
SUN PHARMACEUTICAL INDUSTRIES LTD
APOLLO HOSPITALS ENTERPRISE LTD
TORRENT PHARMACEUTICALS LTD
CIPLA LTD
DIVI''S LABORATORIES LTD
FORTIS HEALTHCARE LTD
AUROBINDO PHARMA LTD
LUPIN LTD
BIOCON LTD
GLENMARK PHARMACEUTICALS LTD
AJANTA PHARMA LTD
ALKEM LABORATORIES LTD
ZYDUS LIFESCIENCES LTD
ABBOTT INDIA LTD
DR LAL PATH LABS LTD
NEULAND LABORATORIES LTD
SYNGENE INTERNATIONAL LTD
ASTER DM QUALITY CARE LTD
ERIS LIFESCIENCES LTD
NARAYANA HRUDAYALAYA LTD
🏦 Top AMC Owners
12.84%
12.50%
10.26%
6.48%
4.80%
4.63%
4.60%
4.25%
3.77%
3.43%
📊 Ownership Insights

GLAXOSMITHKLINE PHARMACEUTICALS LTD is currently held by 95 mutual funds with a combined exposure of 88.66% .

The top 10 mutual funds together account for approximately 34.06% portfolio weight in this company.

This stock is most actively owned by 15 AMCs across multiple mutual fund categories.

🚀 Continue Your Research

Compare Funds Similar Funds Historical SIP Explore Hub
🚀 Explore The Complete Mutual Fund Universe
Discover top-ranked mutual funds, compare schemes, analyze portfolio holdings, explore AMCs, identify category leaders and use powerful investment planning tools — all from one place.
⭐ Top Ranked Funds 🏆 Category Leaders 🏢 AMC Insights 📈 Popular Stocks 🛠 Planning Tools 🔍 Similar Funds
Explore CheckPAN
Browse 7,500+ mutual funds, leading AMCs, portfolio companies and investment insights.
Frequently Asked Questions

This page shows mutual funds that currently invest in GLAXOSMITHKLINE PHARMACEUTICALS LTD, along with their exposure and allocation percentage.

Mutual funds invest in GLAXOSMITHKLINE PHARMACEUTICALS LTD based on factors such as financial performance, growth potential, valuation and sector outlook.

Mutual fund exposure to GLAXOSMITHKLINE PHARMACEUTICALS LTD represents the total percentage of holdings across all mutual fund portfolios combined.

High mutual fund holding in GLAXOSMITHKLINE PHARMACEUTICALS LTD indicates institutional interest, but it should be analyzed along with fundamentals and market conditions.

Yes, mutual funds frequently adjust their holdings in GLAXOSMITHKLINE PHARMACEUTICALS LTD based on market conditions and investment strategy.

Multiple AMCs may invest in GLAXOSMITHKLINE PHARMACEUTICALS LTD depending on their fund strategy, sector allocation and risk profile.

GLAXOSMITHKLINE PHARMACEUTICALS LTD belongs to a specific industry sector which influences its inclusion in mutual fund portfolios.

Yes, you can track changes in mutual fund holdings of GLAXOSMITHKLINE PHARMACEUTICALS LTD whenever new portfolio disclosures are released.

Mutual fund ownership can influence liquidity and demand, but stock price is affected by multiple market and business factors.

You can analyze institutional investment in GLAXOSMITHKLINE PHARMACEUTICALS LTD by reviewing mutual fund holdings, allocation trends and ownership concentration.
© 2026 CheckPan